Literature DB >> 24882694

CFTR functional measurements in human models for diagnosis, prognosis and personalized therapy: Report on the pre-conference meeting to the 11th ECFS Basic Science Conference, Malta, 26-29 March 2014.

Jeffrey M Beekman1, Isabelle Sermet-Gaudelus2, Kris de Boeck3, Tanja Gonska4, Nico Derichs5, Marcus A Mall6, Anil Mehta7, Ulrich Martin8, Mitch Drumm9, Margarida D Amaral10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24882694     DOI： 10.1016/j.jcf.2014.05.007

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


× No keyword cloud information.
  14 in total

1.  Finding new drugs to enhance anion secretion in cystic fibrosis: Toward suitable systems for better drug screening. Report on the pre-conference meeting to the 12th ECFS Basic Science Conference, Albufeira, 25-28 March 2015.

Authors:  Alan S Verkman; Aleksander Edelman; Margarida Amaral; Marcus A Mall; Jeffrey M Beekman; Torsten Meiners; Luis J V Galietta; Christine E Bear
Journal:  J Cyst Fibros       Date:  2015-10-21       Impact factor: 5.482

Review 2.  The third dimension: new developments in cell culture models for colorectal research.

Authors:  Joana F S Pereira; Nikhil T Awatade; Cláudia A Loureiro; Paulo Matos; Margarida D Amaral; Peter Jordan
Journal:  Cell Mol Life Sci       Date:  2016-05-04       Impact factor: 9.261

3.  Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD).

Authors:  George M Solomon; Inez Bronsveld; Kathryn Hayes; Michael Wilschanski; Paola Melotti; Steven M Rowe; Isabelle Sermet-Gaudelus
Journal:  J Vis Exp       Date:  2018-09-13       Impact factor: 1.355

Review 4.  Toward inclusive therapy with CFTR modulators: Progress and challenges.

Authors:  Jennifer Guimbellot; Jyoti Sharma; Steven M Rowe
Journal:  Pediatr Pulmonol       Date:  2017-09-07

Review 5.  Hallmarks of therapeutic management of the cystic fibrosis functional landscape.

Authors:  Margarida D Amaral; William E Balch
Journal:  J Cyst Fibros       Date:  2015-10-29       Impact factor: 5.482

6.  Nasal potential difference in cystic fibrosis considering severe CFTR mutations.

Authors:  Ronny Tah Yen Ng; Fernando Augusto de Lima Marson; Jose Dirceu Ribeiro; Antonio Fernando Ribeiro; Carmen Silvia Bertuzzo; Maria Angela Gonçalves de Oliveira Ribeiro; Silvana Dalge Severino; Eulalia Sakano
Journal:  Dis Markers       Date:  2015-01-15       Impact factor: 3.434

7.  Increased efficacy of VX-809 in different cellular systems results from an early stabilization effect of F508del-CFTR.

Authors:  Carlos M Farinha; Marisa Sousa; Sara Canato; André Schmidt; Inna Uliyakina; Margarida D Amaral
Journal:  Pharmacol Res Perspect       Date:  2015-06-11

8.  Using Drugs to Probe the Variability of Trans-Epithelial Airway Resistance.

Authors:  Kendra Tosoni; Diane Cassidy; Barry Kerr; Stephen C Land; Anil Mehta
Journal:  PLoS One       Date:  2016-02-29       Impact factor: 3.240

9.  Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.

Authors:  Rodrigo Abensur Athanazio; Luiz Vicente Ribeiro Ferreira da Silva Filho; Alberto Andrade Vergara; Antônio Fernando Ribeiro; Carlos Antônio Riedi; Elenara da Fonseca Andrade Procianoy; Fabíola Villac Adde; Francisco José Caldeira Reis; José Dirceu Ribeiro; Lídia Alice Torres; Marcelo Bicalho de Fuccio; Matias Epifanio; Mônica de Cássia Firmida; Neiva Damaceno; Norberto Ludwig-Neto; Paulo José Cauduro Maróstica; Samia Zahi Rached; Suzana Fonseca de Oliveira Melo
Journal:  J Bras Pneumol       Date:  2017 May-Jun       Impact factor: 2.624

Review 10.  Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis.

Authors:  Simon Y Graeber; Constanze Vitzthum; Marcus A Mall
Journal:  J Pers Med       Date:  2021-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.